lenalidomid "sun" 15 mg kapsler, hårde
sun pharmaceutical industries europe bv - lenalidomid - kapsler, hårde - 15 mg
lenalidomid "sun" 20 mg kapsler, hårde
sun pharmaceutical industries europe bv - lenalidomid - kapsler, hårde - 20 mg
lenalidomid "sun" 25 mg kapsler, hårde
sun pharmaceutical industries europe bv - lenalidomid - kapsler, hårde - 25 mg
lenalidomid "sun" 5 mg kapsler, hårde
sun pharmaceutical industries europe bv - lenalidomid - kapsler, hårde - 5 mg
lenalidomid "sun" 7,5 mg kapsler, hårde
sun pharmaceutical industries europe bv - lenalidomid - kapsler, hårde - 7,5 mg
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastiske midler - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
trabektedin "sun" 1 mg pulver til koncentrat til infusionsvæske, opløsning
sun pharmaceutical industries europe bv - trabectedin - pulver til koncentrat til infusionsvæske, opløsning - 1 mg
rosunogra 10 mg filmovertrukne tabletter
aristo pharma gmbh - rosuvastatin calcium - filmovertrukne tabletter - 10 mg
rosunogra 20 mg filmovertrukne tabletter
aristo pharma gmbh - rosuvastatin calcium - filmovertrukne tabletter - 20 mg